Catherine Godson

Professor Catherine Godson, Full Professor of Molecular Medicine at the School of Medicine, University College Dublin, is a leading international researcher in inflammation resolution and diabetic complications. She directs the UCD Diabetes Complications Research Centre and oversees a multidisciplinary team spanning PhD students, postdocs, clinicians, and industry collaborators.

• BSc and PhD in Biochemistry/Pharmacology from UCD
• Postdoctoral training at University of Geneva and UC San Diego
• Academic career at Harvard (1994-1997) before returning to UCD

Her research focuses on microvascular complications of diabetes and resolution of inflammation, particularly in diabetic kidney disease. Key contributions include identifying novel therapeutic targets through genomic studies and developing lipoxin-based therapies for fibrosis and inflammation. Her work integrates mitochondrial genetics, epigenetics, and multi-omics approaches to uncover disease mechanisms.

Recent publications highlight her team's discoveries in genetic variants affecting kidney function, lipoxin mimetics for inflammation resolution, and mitochondrial-nuclear interactions in metabolic diseases. Collaborations span Monash University, Bart's Charity, and European Diabetic Nephropathy Study Group.

• Scientific leadership in Royal Irish Academy (2011-) and European Medical Research Council (2008-2012)
• Women in Science Award (2019) from International Congress of Inflammation
• Grant funding from Science Foundation Ireland, Wellcome Trust, and EU programs

She has supervised PhD students like Monica deGaetano and Darrell Andrews, and her lab's work appears in journals such as Journal of the American Society of Nephrology and Nature Communications. Current research emphasizes PPARα-regulated fatty acid oxidation and multi-omic integration for precision medicine in diabetes complications.